This Friday evening, the first shipment of Abdala vaccine against Covid-19 from Cuba arrived at the “Felipe Ángeles” International Airport (AIFA).
This comes nearly a year after the Federal Commission on Health Risk Protection (Cofepris) approved its emergency use on December 29.
The Federal Ministry of Health has indicated that this first shipment has transferred 4 million 92 thousand 500 packaged doses to Mexican territory, which will be intended to be applied to adults.
The arrival was registered at 19:57 at the terminal located in Zumpango, in the State of Mexico. The vaccines arrived on the Mexican Air Force Hercules plane from Havana.
Staff of the Biological and Reagent Laboratories of Mexico (Birmex), the National Center for Child and Adolescent Health (Censia) and the Federal Commission for Protection from Health Risks (Cofepris), as well as elements of the Mexican Army and National Guard.
With the doses arrived and since the first shipment arrived in the country on December 23, 2020, Mexico received 193 million 231 thousand 845 packaged vaccines from Pfizer-BioNTech, AstraZeneca, Sinovac, Gamaleya National Research Center for Epidemiology and Microbiology, CanSino Biologics, Johnson & Johnson, Moderna and Abdala.
Similarly, in Mexico, the Drugmex laboratory packaged 14 million 24 thousand 840 doses of CanSino Biologics, and the Liomont laboratory 42 million 991 thousand 100 AstraZeneca biologicals, for a total of 57 million 15 thousand 940 vaccines packaged in the country.
In short, from 23 December 2020 Mexico 250 million 247 thousand 785 organics were available. To date, 217 shipments have been received on 231 flights.
The Abdala vaccine, with the distinctive name: recombinant protein of the receptor binding domain of the SARS-CoV-2 virus, was the first Cuban biologic approved by the Mexican authorities for emergency use against Covid-19.
On November 19, Cofepris announced that it had authorized the emergency use of the Sovereign vaccine, also of Cuban origin.
